IP Library › Assignment 032665/0086
Patent Assignment
Reel/Frame 032665/0086

Assignment of Assignor's Interest

Recorded: 2014-04-14 Pages: 10
Assignor
WAGNER, THOMAS E.
Executed: 2014-04-04
Assignee
ORBIS HEALTH SOLUTIONS LLC
SUITES E & F, 111 SMITH HINES ROAD, GREENVILLE, SOUTH CAROLINA, 29607
Covered Properties (10)
Hybrid Cells
Patent: 6,849,451 →
Application: 09/756,293 →
Publication: US 2001/0049142
Therapeutic Pore-Forming Peptides
Patent: 7,094,750 →
Application: 09/851,422 →
Publication: US 2002/0077454
Lytic Peptide Prodrugs
Patent: 7,456,146 →
Application: 09/938,623 →
Publication: US 2002/0045736
Monocyte-Specific Particulate Delivery Vehicle
Patent: 6,875,612 →
Application: 10/112,036 →
Publication: US 2002/0155609
Vegf Receptor Antagonists
Patent: 7,582,726 →
Application: 10/985,013 →
Publication: US 2005/0196396
Therapeutic Pore-Forming Peptides
Patent: 7,425,535 →
Application: 11/123,182 →
Publication: US 2005/0267031
Acetylated Therapeutic Procytotoxins
Patent: 7,550,426 →
Application: 11/131,443 →
Publication: US 2006/0264364
Polypeptides Comprising Fas Activation and NKG2D-Ligand Domains
Patent: 7,777,004 →
Application: 11/945,747 →
Publication: US 2008/0242610
Hybrid Cells for Treating Cancer Patients
Patent: 8,785,186 →
Application: 12/461,760 →
Publication: US 2010/0047288
Polypeptides Comprising Fas Activation and NKG2D-Ligand Domains
Patent: 8,541,560 →
Application: 12/826,544 →
Publication: US 2010/0284975
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 31, 2009
From: GHC RESEARCH DEVELOPMENT CORPORATION AND GREENVILLE HOSPITAL SYSTEM
To: WAGNER, THOMAS E.
Reel/Frame 023720/0296 →